NMNatalie Meyer

Natalie Meyer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Natalie Meyer has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    An intraoperative methylene blue test can guide patient selection for totally tubeless PCNL

    by Jean Lee, Natalie Meyer, Dyandra Parikesit, Brian Dick, Jorge Mena, Tad Manalo, Hunter Flores, Ryan Ferreira, Mustafa Saeed, Melissa Wong, et al.

    Introduction and Objective: Totally tubeless percutaneous nephrolithotomy (PCNL) has been demonstrated to be feasible and safe, particularly for mini-PCNL. Having an objective test to guide patient selection could improve confidence in this practice and facilitate broader adoption. The purpose of this study was to evaluate the utility of an intraoperative methylene blue test to determine candidacy for totally tubeless PCNL. Methods: Adult patients undergoing PCNL at four institutions were included in this study. Patients with prior reconstructive surgery, chronic pain, or requiring ureteral dilation were excluded. After stone clearance, 10 mL methylene blue (MB) dye was injected into the percutaneous access tract. A positive test (“pass”) was defined as visualization of blue dye in the bladder catheter within two minutes of injection. In some standard PCNL cases, totally tubeless management was simulated by placement of a capped nephrostomy tube. Post-operative complications within 7 days were evaluated as the primary outcome. Results: The intraoperative MB test was performed in 91 PCNL cases: 60 mini-PCNLs (16 Fr access) and 31 standard PCNLs (24+ Fr access). Mini-PCNL cases were more likely to pass the MB test compared to standard PCNL cases (75% vs 38.7%, p = 0.001). Of the 45 mini-PCNL subjects who passed, 40 were left totally tubeless, resulting in two minor complications (urinary retention, obstructing ureteral stone fragment). In the standard PCNL cohort, 12 passed the MB test. Five were left totally tubeless and 3 simulated totally tubeless management with capped nephrostomy tubes; one subject had a transient postoperative creatinine elevation, and one required uncapping for steinstrasse. There were no other obstructive or infectious complications, and no surgical reintervention was required. Conclusions: An intraoperative methylene blue test is a simple test with high positive-predictive value to determine candidacy for totally tubeless PCNL in real time for both mini and standard PCNLs.

  • Open Access

    Endoscopically visible Randall’s plaques are an independent predictor of future stone events

    by Natalie R Meyer, Jean Lee, Victoria Liu, Lejla Pepic, Robert Pearce, Kevin Li, Kevin Shee, Jorge Mena, Justin Ahn, David Bayne, et al.

    Introduction and objectives: Randall’s plaques have been long thought to be precursors for kidney stone formation, but how their presence impacts future stone recurrence is not known. The aim of this study was to determine whether patients with endoscopically visible plaques were more likely to have subsequent stone events compared to those without. Methods: The presence of Randall’s plaque in adult patients was prospectively assessed during endoscopic cases as part of the Registry for Stones of the Kidney and Ureter (ReSKU). In each case, the visible Randall’s plaque burden was scored by the attending surgeon as “none,” “minimal,” or “many.” Data regarding stone composition, 24-hour urine tests, and subsequent stone events on follow up were collected. Stone events were defined as patient-reported stone passage or any primary operation for kidney stones; second-look or staged operations were not counted as separate stone events. Results: We identified 673 subjects with a Randall’s plaque assessment, of which 78 had “none,” 306 had “minimal,” and 289 had “many.” Despite having no significant differences in initial stone burden, subjects with visible Randall’s plaque (“minimal” or “many”) had a higher relative risk of stone recurrences after surgery compared to those without (RRR 1.711 (1.121-2.611), p = 0.01). Interestingly, no significant differences in 24-hour urine analytes were observed. Subjects with visible plaque were more likely to have calcium-based stones (84% vs 58%, p < 0.001). Conclusion: The presence of endoscopically visible Randall’s plaque is associated with an increased risk of stone recurrence independent of urine composition.